Preventive HIV drug shows urgent need for transparency on pricing

The drug cabotegravir could be a game-changer in the fight against HIV/AIDS — but we need to know why it costs so much. The drug cabotegravir could be a game-changer in the fight against HIV/AIDS — but we need to know why it costs so much. Winnie Byanyima holds a red booklet with the words 'in...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 2022-08, Vol.608 (7922), p.239-239
Format: Article
Language:English
Subjects:
631/250/254
631/250/255/1901
692/700/478
706/648/1496
Acquired immune deficiency syndrome
AIDS
Antiretroviral drugs
Disease prevention
Drug dosages
Editorial
Emtricitabine
HIV
Human immunodeficiency virus
Humanities and Social Sciences
multidisciplinary
Nonprofit organizations
Prophylaxis
Science
Tenofovir
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The drug cabotegravir could be a game-changer in the fight against HIV/AIDS — but we need to know why it costs so much. The drug cabotegravir could be a game-changer in the fight against HIV/AIDS — but we need to know why it costs so much. Winnie Byanyima holds a red booklet with the words 'in danger' repeated on the cover
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-022-02136-6